Status:
UNKNOWN
An Intervention to Develop Interface Tools for Nutrigenomics
Lead Sponsor:
Kwantlen Polytechnic University
Collaborating Sponsors:
Natural Sciences and Engineering Research Council, Canada
Conditions:
Adult
Eligibility:
All Genders
35-55 years
Phase:
NA
Brief Summary
This study compares the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to ...
Detailed Description
While nutrition is a widely accepted tool for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential...
Eligibility Criteria
Inclusion
- Adults, aged 35-55 years.
- Ability to understand sign an informed consent and to give a buccal DNA swab.
- Willing to improve their health.
- Medically stable. Subjects diagnosed with diet-related chronic disease were able to enroll in the study, provided that their condition was stabilized or well controlled for at least six months at the time of the baseline visit. Determination of stabilized medical condition was based on established clinical guidelines (e.g., Canadian Diabetes Association Clinical Guidelines and Canadian Cardiovascular Society Guidelines).
Exclusion
- Currently on a therapeutic or restrictive diet (e.g., Atkins).
- Diagnosis of 2 or more chronic diseases or unstable chronic disease as deemed by accepted clinical guidelines.
- Clinical diagnosis of any mental health condition.
- Current or former malignancy for which the participant has undergone resection, radiation therapy or chemotherapy within 5 years prior to baseline.
- Diagnosis of any medical condition or disease, which in the opinion of the Principal Investigator (PI), may have either put the participant at risk, or influenced the results of the study or the participant's ability to participate in the study.
- Diagnosis of any of the following medical conditions: HIV, COPD, severe/uncontrolled asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, chronic renal failure, colon or small intestine problem, liver or kidney disease.
- Currently enrolled or plan to be enrolled in another research study during the course of this investigation.
- Planned or recent (within the last 12 months) bariatric surgery.
- Current use of weight altering medication for the purpose of weight loss.
- Uncorrected hypothyroidism or hyperthyroidism in the previous 12 months.
- Alcohol or drug dependence during the previous 12 months.
- Investigators and their immediate families. Immediate family was defined as a spouse, parent, child or sibling, whether biological or legally adopted.
- Pregnant and/or breastfeeding.
- Current smoker.
- BMI ≥ 35.
- Any other health risk that may have impaired the study's ability to assess the impact of nutrigenomic information to improve diet and health.
- \-
Key Trial Info
Start Date :
March 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT03310814
Start Date
March 15 2017
End Date
December 31 2017
Last Update
October 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Innovation Boulevard
Surrey, British Columbia, Canada